Santé log3h
SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment
FDA confirms that SciSparc’s study may proceed only a month after application submission . TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Co ...
Santé log3h
AssureCare Welcomes Stacy Mountain as Vice President of Sales
CINCINNATI, Sept. 30, 2024 (GLOBE NEWSWIRE) -- AssureCare, a leading provider of Population Health Management solutions, is ...
Santé log3h
Parexel Earns Prestigious Society for Clinical Research Sites Eagle Award for Second Consecutive Year
Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced it has been awarded the 2024 Society ...
Santé log3h
Instinct Report: Morale is Trending Up in 2024, but Employee Turnover Remains High in ER & Specialty Hospitals
PHILADELPHIA, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Instinct Science, a leading technology provider for veterinary hospitals, today announced its second annual State of Emergency and Specialty Veterinary ...
Santé log4h
AB Science annonce un léger décalage de la publication de son rapport financier du premier semestre 2024
AB Science SA (Euronext - FR0010557264 - AB) annonce aujourd'hui le décalage de la publication de son rapport financier du premier semestre 2024, initialement prévue le 30 septembre 2024, pour laisser ...
Santé log4h
MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)
MediciNova holds Orphan Drug Designation for MN-166 (ibudilast) in ALS by U.S. FDA and EU EMA. MN-166 (ibudilast) has received Fast Track Designation by FDA for treatment of ALS. In addition, MN-166 ...
Santé log4h
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, ...
Santé log4h
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly-owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial ...
Santé log2d
ROUGEOLE : La diminution de l’immunité vaccinale est-elle préoccupante
Son incidence a pratiquement doublé dans le monde en 1 an, révélait un récent bilan sur la rougeole. Cette large étude, menée par des épidémiologistes et des virologues de la London School of Hygiene ...
Santé log2d
MICROBIOTE : Comment la galvanotaxie attire les bactéries
Cette bioélectricité intestinale, décrite pour la première fois par une équipe de gastroentérologues et de biologistes de l’University of California (UC) - Davis Health, permet aux mauvaises bactéries ...
Santé log3d
SOGC Calls for Vigilance and Continued Advocacy on International Safe Abortion Day
OTTAWA, Ontario, Sept. 28, 2024 (GLOBE NEWSWIRE) -- As the world observes International Safe Abortion Day, the Society of Obstetricians and Gynaecologists of Canada (SOGC) is reaffirming its ...
Santé log3d
Digicann Ventures Signs Definitive Agreement for Proposed RTO Transaction with 3Win Corp.
The Proposed Transaction is planned to be completed by way of a three-cornered merger pursuant to which, a wholly owned subsidiary of the Company incorporated in Nevada will merge with 3Win and 3Win ...